These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Absence of "recurarization" in patients with demonstrated prolonged neuromuscular block. Lee C; Mok MS; Barnes A; Katz RL Br J Anaesth; 1977 May; 49(5):485-9. PubMed ID: 861117 [TBL] [Abstract][Full Text] [Related]
5. Neuromuscular blocking drugs in anaesthesia. Donati F; Bevan JC; Bevan DR Can Anaesth Soc J; 1984 May; 31(3 Pt 1):324-36. PubMed ID: 6372957 [No Abstract] [Full Text] [Related]
6. Pre- and postjunctional effects of neuromuscular blocking agents and their antagonists. Jones RM; Williams JP; Pearce AC Anesth Analg; 1983 Dec; 62(12):1137-8. PubMed ID: 6650902 [No Abstract] [Full Text] [Related]
7. Reversal of neuromuscular blockade. Ramsey FM Int Anesthesiol Clin; 1991; 29(2):93-104. PubMed ID: 2071225 [TBL] [Abstract][Full Text] [Related]
8. Fluid, electrolyte, and acid-base balance in the renal patient. Pickering L; Robbins D Nurs Clin North Am; 1980 Sep; 15(3):577-92. PubMed ID: 7003556 [No Abstract] [Full Text] [Related]
13. Neuromuscular pharmacology. A clinical update and commentary. Lee C; Katz RL Br J Anaesth; 1980 Feb; 52(2):173-88. PubMed ID: 6244842 [No Abstract] [Full Text] [Related]
14. Applied pharmacology of common neuromuscular blocking agents in critical care. Prielipp RC; Coursin DB New Horiz; 1994 Feb; 2(1):34-47. PubMed ID: 7922428 [TBL] [Abstract][Full Text] [Related]
15. Have we learned how to relax our patients, by thinking outside the box? Lee C; Katz RL J Crit Care; 2009 Mar; 24(1):1-4. PubMed ID: 19272532 [No Abstract] [Full Text] [Related]
16. Dose-response relationships for edrophonium and neostigmine antagonism of atracurium and cisatracurium-induced neuromuscular block. Naguib M; Riad W Can J Anaesth; 2000 Nov; 47(11):1074-81. PubMed ID: 11097536 [TBL] [Abstract][Full Text] [Related]
17. [Antagonists of neuromuscular blockade--mechanisms of action, adverse effects and dosages]. Schuh FT Klin Anasthesiol Intensivther; 1980; 22():158-74. PubMed ID: 6108384 [No Abstract] [Full Text] [Related]
18. New approaches to reversal of neuromuscular block. Bom A; Clark JK; Palin R Curr Opin Drug Discov Devel; 2002 Sep; 5(5):793-800. PubMed ID: 12630300 [TBL] [Abstract][Full Text] [Related]
19. Determinants of the reversal time of competitive neuromuscular block by anticholinesterases. Beemer GH; Bjorksten AR; Dawson PJ; Dawson RJ; Heenan PJ; Robertson BA Br J Anaesth; 1991 Apr; 66(4):469-75. PubMed ID: 2025474 [TBL] [Abstract][Full Text] [Related]
20. Muscle relaxants and reversal agents. Van Sickel AD; Spadaccia K Crit Care Nurs Clin North Am; 1991 Mar; 3(1):151-8. PubMed ID: 2043325 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]